New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.
Saved in:
| Title: | New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. |
|---|---|
| Authors: | Burgin D; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Périer C; Ipsen Innovation, 5 Avenue du Canada, 91940 Les Ulis, France., Hackett G; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Elliott M; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Kwan D; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Hornby F; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Mir I; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Maignel J; Ipsen Innovation, 5 Avenue du Canada, 91940 Les Ulis, France., Liu SM; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK., Beard M; Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK. |
| Source: | Toxins [Toxins (Basel)] 2021 Nov 24; Vol. 13 (12). Date of Electronic Publication: 2021 Nov 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651 (Electronic) Linking ISSN: 20726651 NLM ISO Abbreviation: Toxins (Basel) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
